LENZ Therapeutics Statistics

Total Valuation

LENZ has a market cap or net worth of $416.71 million. The enterprise value is $203.47 million.

Market Cap	416.71M
Enterprise Value	203.47M

Important Dates

The last earnings date was Wednesday, May 8, 2024, after market close.

Earnings Date	May 8, 2024
Ex-Dividend Date	Mar 22, 2024

Share Statistics

LENZ has 25.53 million shares outstanding. The number of shares has increased by 141.85% in one year.

Shares Outstanding	25.53M
Shares Change (YoY)	+141.85%
Shares Change (QoQ)	-42.88%
Owned by Insiders (%)	5.69%
Owned by Institutions (%)	74.55%
Float	9.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.10
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.47, with a Debt / Equity ratio of 0.00.

Current Ratio	11.47
Quick Ratio	n/a
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -88.00% and return on invested capital (ROIC) is -62.94%.

Return on Equity (ROE)	-88.00%
Return on Assets (ROA)	-55.80%
Return on Capital (ROIC)	-62.94%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.55% in the last 52 weeks.

Beta (1Y)	n/a
52-Week Price Change	-20.55%
50-Day Moving Average	18.97
200-Day Moving Average	18.09
Relative Strength Index (RSI)	44.72
Average Volume (30 Days)	284,550

Short Selling Information

The latest short interest is 473,047, so 1.85% of the outstanding shares have been sold short.

Short Interest	473,047
Short Previous Month	307,948
Short % of Shares Out	1.85%
Short % of Float	4.90%
Short Ratio (days to cover)	0.51

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-124.83M
Pretax Income	-117.37M
Net Income	-117.37M
EBITDA	-112.88M
EBIT	-117.37M
Earnings Per Share (EPS)	-$15.85

Full Income Statement

Balance Sheet

The company has $213.39 million in cash and $156,000 in debt, giving a net cash position of $213.24 million or $8.35 per share.

Cash & Cash Equivalents	213.39M
Total Debt	156,000
Net Cash	213.24M
Net Cash Per Share	$8.35
Equity / Book Value	198.17M
Book Value Per Share	7.76
Working Capital	197.79M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$92.87 million and capital expenditures -$8.57 million, giving a free cash flow of -$101.44 million.

Operating Cash Flow	-92.87M
Capital Expenditures	-8.57M
Free Cash Flow	-101.44M
FCF Per Share	-$21.50

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of $7.21, which amounts to a dividend yield of 44.10%.

Dividend Per Share	$7.21
Dividend Yield	44.10%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-141.85%
Shareholder Yield	-97.75%
Earnings Yield	-28.16%
FCF Yield	-24.34%

Dividend Details

Analyst Forecast

The average price target for LENZ is $31.33, which is 91.62% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$31.33
Price Target Difference	91.62%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 22, 2024. It was a reverse split with a ratio of 1:7.

Last Split Date	Mar 22, 2024
Split Type	Reverse
Split Ratio	1:7

Scores

Altman Z-Score	n/a
Piotroski F-Score	2